Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Prostate cancer patients with docetaxel therapy 2) Patients who are over 20 years old and who have obtained informed consent
Exclusion criteria
Exclusion criteria: 1) Patients with peripheral neuropathy at the start of the study 2) Patients who have received medication that may cause peripheral neuropathy in the past. 3) Other patients who are judged inappropriate by the research doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Presence of peripheral neuropathy at the end of 10 courses Grade 1 or higher is judged to be peripheral neuropathy, and Grade 0 or higher is judged to be no peripheral neuropathy based on the CTCAE ver 5.0. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the nails at the end of the 10 courses Based on the CTCAE ver 5.0, the "Peripheral Nerve Damage and Nail Questionnaire" is used to evaluate Grade 1 or higher as nail damage and Grade 0 as no nail damage. | — |
Countries
Japan
Contacts
Kagawa university Department of Urology, faculty of medicine